Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AZD 5492

Next Previous
X
Search
Drug Profile

AZD 5492

Alternative Names: AZD-5492

Latest Information Update: 10 Oct 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AstraZeneca
  • Class Antibodies; Antineoplastics; Immunoglobulin fragments; Immunotherapies
  • Mechanism of Action Antibody-dependent cell cytotoxicity; CD20 antigen inhibitors; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II B-cell lymphoma; Chronic lymphocytic leukaemia; Follicular lymphoma; Mantle-cell lymphoma

Most Recent Events

  • 18 Sep 2024 Phase-I/II clinical trials in B-cell lymphoma (Second-line therapy or greater, Monotherapy) in Japan, Spain, Italy, Denmark, France, Germany, Australia, Canada, USA (SC) (NCT06542250)
  • 18 Sep 2024 Phase-I/II clinical trials in Chronic lymphocytic leukaemia (Second-line therapy or greater, Monotherapy) in Japan, Germany, Canada, Australia, Denmark, Spain, Italy, France, USA (SC) (NCT06542250)
  • 18 Sep 2024 Phase-I/II clinical trials in Follicular lymphoma (Second-line therapy or greater, Monotherapy) in Germany, Denmark, Spain, France, Italy, Australia, USA, Canada, Japan (SC) (NCT06542250)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top